HDFC Pharma and Healthcare Fund - Direct - Growth

A Equity Scheme by HDFC Asset Management Company Limited

1Y Returns (CAGR)
10.70%
Expense Ratio
0.93%

as of 01/03/2026

AUM
₹662.16 Cr

Qtr End: Dec 25

NAV
₹18.363

as of 17/04/2026

Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
Period
Returns
CAGR
Volatility
3M5.72%24.90%17.74%
6M3.01%6.10%14.54%
1Y10.70%10.70%13.24%
3YN/AN/AN/A
5YN/AN/AN/A
Scheme Details
Launch Date
14/09/2023
Fund Age
2.6 years
Minimum Investment
₹100
Fund House
HDFC Mutual Fund
Category
Equity Scheme
Sub-category
Sectoral/ Thematic (Equity Scheme)

Frequently Asked Questions